Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
Purpose
Assess the impact of steroid, diuretic, and fluid practices on BPD outcomes in extreme premature infants in the Banner - University Medical Center Phoenix (BUMCP) neonatal intensive care unit (NICU).
Condition
- BPD - Bronchopulmonary Dysplasia
Eligibility
- Eligible Ages
- All ages
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Infants born at <30 weeks and/or <1500g - Admitted to BUMCP between January 1, 2019 and December 31, 2020
Exclusion Criteria
- Infants that do not survive to 36 weeks CGA, when the determination of BPD is made - Infants that are transferred to another hospital prior to 36 weeks CGA - Out born infants - Infants with life threatening congenital anomalies - Investigator discretion as to other factors which might impact the study
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Case-Only
- Time Perspective
- Retrospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Inclusion Group | Infants born at <30 weeks and/or <1500g that were admitted to BUMCP between January 1, 2019 and December 31, 2020 |
|
Recruiting Locations
Banner University Medical Center Phoenix
Phoenix, Arizona 85006
Phoenix, Arizona 85006
More Details
- Status
- Recruiting
- Sponsor
- Pediatrix
Detailed Description
The investigators propose performing a retrospective analysis of the current respiratory management methods to potentially find a correlation between the number of steroid doses administered, the timing of initiation of steroid therapy and the effect on premature infants at risk for developing BPD. The investigators are also going to explore the number and timing of diuretic medications and average fluid intake.